These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 25651718

  • 1. Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy.
    Shen P, Shen J, Li W, He L.
    Clin Lab; 2014; 60(10):1709-15. PubMed ID: 25651718
    [Abstract] [Full Text] [Related]

  • 2. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R, Asanuma K, Kodama F, Akiba-Takagi M, Nagai-Hosoe Y, Seki T, Takeda Y, Ohsawa I, Mano S, Matsuoka K, Kurosawa H, Ogasawara S, Hirayama Y, Sekine S, Horikoshi S, Hara M, Tomino Y.
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, Zhu XJ, Liu FY.
    Ren Fail; 2012 Sep; 34(7):821-6. PubMed ID: 22679920
    [Abstract] [Full Text] [Related]

  • 4. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
    Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S.
    Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
    [Abstract] [Full Text] [Related]

  • 5. Urinary and glomerular podocytes in patients with chronic kidney diseases.
    Hanamura K, Tojo A, Fujita T.
    Clin Exp Nephrol; 2014 Feb; 18(1):95-103. PubMed ID: 23670304
    [Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.
    Am J Nephrol; 2000 Feb; 20(5):373-9. PubMed ID: 11092994
    [Abstract] [Full Text] [Related]

  • 7. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy.
    Kodama F, Asanuma K, Takagi M, Hidaka T, Asanuma E, Fukuda H, Seki T, Takeda Y, Hosoe-Nagai Y, Asao R, Horikoshi S, Tomino Y.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1762-72. PubMed ID: 23143340
    [Abstract] [Full Text] [Related]

  • 8. Podocytopenia and disease severity in IgA nephropathy.
    Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD.
    Kidney Int; 2002 Apr; 61(4):1475-85. PubMed ID: 11918755
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
    Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG.
    Korean J Intern Med; 2014 May; 29(3):334-40. PubMed ID: 24851068
    [Abstract] [Full Text] [Related]

  • 10. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.
    Akankwasa G, Jianhua L, Guixue C, Changjuan A, Xiaosong Q.
    Biomark Med; 2018 Aug; 12(8):927-935. PubMed ID: 29976076
    [Abstract] [Full Text] [Related]

  • 11. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
    Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T.
    J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
    [Abstract] [Full Text] [Related]

  • 12. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy.
    Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Tam KY, Xiao J, Lai FM, Tang SC.
    Nephrol Dial Transplant; 2009 Jan; 24(1):62-72. PubMed ID: 18685143
    [Abstract] [Full Text] [Related]

  • 13. [Significance of detecting urinary podocytes in patients with active glomerulonephritis].
    Li JZ, Huang HC, Liu Y, E J.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct 18; 37(5):463-6. PubMed ID: 16224513
    [Abstract] [Full Text] [Related]

  • 14. Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.
    Suwanpen C, Nouanthong P, Jaruvongvanich V, Pongpirul K, Pongpirul WA, Leelahavanichkul A, Kanjanabuch T.
    J Nephrol; 2016 Feb 18; 29(1):37-44. PubMed ID: 25905599
    [Abstract] [Full Text] [Related]

  • 15. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis.
    Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, Yamamoto T, Kihara I.
    Am J Nephrol; 1998 Feb 18; 18(1):35-41. PubMed ID: 9481437
    [Abstract] [Full Text] [Related]

  • 16. [A study of urinary podocalyxin in children with IgA nephropathy].
    Okubo S.
    Nihon Jinzo Gakkai Shi; 1995 Jul 18; 37(7):357-65. PubMed ID: 7637206
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.
    Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2013 Jul 18; 8(8):e73425. PubMed ID: 24023680
    [Abstract] [Full Text] [Related]

  • 18. Mitofusin2 expression is associated with podocyte injury in IgA nephropathy.
    Tang X, Yuan Y, Liang X, Jiang X.
    Eur J Med Res; 2023 Mar 30; 28(1):142. PubMed ID: 36998021
    [Abstract] [Full Text] [Related]

  • 19. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis.
    Hara M, Yanagihara T, Kihara I.
    Clin J Am Soc Nephrol; 2007 Mar 30; 2(2):231-8. PubMed ID: 17699418
    [Abstract] [Full Text] [Related]

  • 20. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
    Rong ZH, Wang C, Hao J, Duan HJ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May 30; 20(5):275-8. PubMed ID: 18471357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.